On the other hand, many reports documented that TGF-β-induced activation of SMADs also suppresses tumor formation and development by blocking the cell cycle and arresting cell growth [53] in breast cancer cell lines [54], liver cancer cells [55], and normal epithelial cells [56]. This evidence concerns the gene TGFB1 and breast carcinoma.